Literature DB >> 23931616

Incidence and clinicopathological characteristics of intraductal carcinoma detected in prostate biopsies: a prospective cohort study.

Katherine Watts1, Jianbo Li, Cristina Magi-Galluzzi, Ming Zhou.   

Abstract

AIMS: Intraductal carcinoma of the prostate (IDC-P) is a distinct clinicopathological entity and is associated with aggressive, high-grade and high-volume prostate carcinoma (PCa). The incidence, clinicopathological characteristics and prognostic significance of IDC-P have not been reported in prostate biopsies (PBx) that surgical pathologists encounter in their daily practice. METHODS AND
RESULTS: In 1176 prospectively collected PBx, 33 IDC-P cases were identified (2.8%). The mean age of patients with IDC-P was 65 (range 46-79) years and mean serum prostate-specific antigen was 16.2 (range 0.4-105.6) ng/ml. Three (0.26%) IDC-P cases did not have a concomitant invasive PCa. Of 30 cases with concomitant invasive PCa, Gleason score was 7 in 16 (53.3%), 8 in four (13.3%) and 9 in 10 (33.3%) cases. The mean number of biopsy cores involved by PCa was 7.2 (range 1-14). Nine patients were treated with radical prostatectomy. Seminal vesicle invasion was found in four of nine (44%) cases, significantly higher than the risk of 12% predicted by Partin Tables (P = 0.016).
CONCLUSIONS: This is the first prospective study that has investigated the incidence and prognostic significance of IDC-P diagnosed in PBx encountered in daily practice. It is critical for surgical pathologists to diagnose and report IDC-P in PBx.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  biopsy; intraductal carcinoma; prognosis; prostate cancer

Mesh:

Year:  2013        PMID: 23931616     DOI: 10.1111/his.12198

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  23 in total

1.  [The 2014 consensus conference of the ISUP on Gleason grading of prostatic carcinoma].

Authors:  G Kristiansen; L Egevad; M Amin; B Delahunt; J R Srigley; P A Humphrey; J I Epstein
Journal:  Pathologe       Date:  2016-02       Impact factor: 1.011

Review 2.  Intraductal carcinoma of prostate (IDC-P): from obscure to significant.

Authors:  Ni Chen; Qiao Zhou
Journal:  Chin J Cancer Res       Date:  2016-02       Impact factor: 5.087

Review 3.  Intraductal carcinoma of prostate: a comprehensive and concise review.

Authors:  Jordan A Roberts; Ming Zhou; Yong Wook Park; Yong Wok Park; Jae Y Ro
Journal:  Korean J Pathol       Date:  2013-08-26

Review 4.  Grading of Prostate Cancer: Past, Present, and Future.

Authors:  Andres Matoso; Jonathan I Epstein
Journal:  Curr Urol Rep       Date:  2016-03       Impact factor: 3.092

Review 5.  [Intraductal carcinoma of the prostate].

Authors:  G Kristiansen; M Varma; G Seitz
Journal:  Pathologe       Date:  2016-02       Impact factor: 1.011

Review 6.  Histopathology of Prostate Cancer.

Authors:  Peter A Humphrey
Journal:  Cold Spring Harb Perspect Med       Date:  2017-10-03       Impact factor: 6.915

7.  Utility of PTEN and ERG immunostaining for distinguishing high-grade PIN from intraductal carcinoma of the prostate on needle biopsy.

Authors:  Carlos L Morais; Jeong S Han; Jennifer Gordetsky; Michael S Nagar; Ann E Anderson; Stephen Lee; Jessica L Hicks; Ming Zhou; Cristina Magi-Galluzzi; Rajal B Shah; Jonathan I Epstein; Angelo M De Marzo; Tamara L Lotan
Journal:  Am J Surg Pathol       Date:  2015-02       Impact factor: 6.394

8.  Target prostate biopsies: How best to report in synoptic format?

Authors:  Michelle R Downes; John R Srigley; Andrew Loblaw; Nathan Perlis; Sangeet Ghai; Theodorus van der Kwast
Journal:  Can Urol Assoc J       Date:  2022-04       Impact factor: 1.862

9.  Disease-specific survival of patients with invasive cribriform and intraductal prostate cancer at diagnostic biopsy.

Authors:  Charlotte F Kweldam; Intan P Kümmerlin; Daan Nieboer; Esther I Verhoef; Ewout W Steyerberg; Theodorus H van der Kwast; Monique J Roobol; Geert J van Leenders
Journal:  Mod Pathol       Date:  2016-03-04       Impact factor: 7.842

Review 10.  Current Understanding and Management of Intraductal Carcinoma of the Prostate.

Authors:  Bryden Considine; Adebowale Adeniran; Michael E Hurwitz
Journal:  Curr Oncol Rep       Date:  2021-07-16       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.